Zeotech Limited announced that it has provided a range of Type A molecular sieve zeolites to a leading Australian manufacturer of advanced animal feed additives `Bioproton', for in-vitro screening of mycotoxin binding, across seven toxins. Zeotech and Bioproton will assess the initial test results to evaluate the potential of utilising synthetic zeolites to develop targeted mycotoxin binder product(s). The global mycotoxin detoxifier additives market (binder/adsorbents) is valued at over AUD $1.1 billion and growing at 5% per annum 1. Mycotoxins are naturally occurring toxins produced by certain moulds (filamentous fungi), many of which have been implicated as chemical progenitors of toxicity in humans and animals and can be the source of various negative health effects. They can cause a toxic response (mycotoxicosis) when ingested posing a significant health danger to livestock, horses, companion animals, and humans. Mycotoxins reduce weight gain and growth rate and increase mortality. Some of the effects include tumour growth, anaemia, kidney and liver damage, reproductive disorders, and immunosuppression. The moulds that create mycotoxin (in animal feeds) develop on various foodstuffs, corn, grains, and various other crops. They can occur in the field (depending on weather conditions), after harvest (depending on conditions), during storage (improper storage), or on the food under warm and humid conditions - as a consequence of climate change, mycotoxins are increasing occurring. The objective of the program is to progress to a comprehensive commercial collaboration with Bioproton. Zeotech has provided 3A, 4A and 5A molecular sieve zeolites for the program, which will incorporate the following 7 mycotoxin tests across under 2 pH conditions (acid and neutral). The toxins to be tested are: Aflatoxin B1; Fumonisin B1; Deoxynivalenol; Ochratoxin A; Zearalenone; T-2 Toxin; and Ergotamine. The testing fees for mycotoxin in-vitro screening program are not material to the company.